SPOTLIGHT: Finneran resigns from council

The controversy over Thomas Finneran's agreement to plead guilty to a felony on Friday proved fatal to his attempt to remain as head of the Massachusetts Biotechnology Council. Finneran, the former House speaker and prominent Democrat, turned in his resignation yesterday. Report

Suggested Articles

Biogen unveiled full phase 1/2 for a prospect that emerged from a shift in its thinking about treating amyotrophic lateral sclerosis.

It took a little longer than expected, but Biogen’s done it—along with partner Eisai, the Big Biotech has completed an FDA filing for aducanumab.

Gilead is ditching a new avenue of treating hepatitis B as it cuts ties with Precision Biosciences less than two years into their research pact.